DC50292A
/ CR Double-Crane
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 17, 2025
A Phase 1 Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Heronova Pharmaceuticals
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1